These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 11808853)

  • 1. Sporadic failure of botulinum toxin treatment in usually responsive patients with adductor spasmodic dysphonia.
    Galardi G; Guerriero R; Amadio S; Leocani L; Teggi R; Melloni G; Comi G
    Neurol Sci; 2001 Aug; 22(4):303-6. PubMed ID: 11808853
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The use of botulinum toxin in the treatment of adductor spasmodic dysphonia.
    Whurr R; Lorch M; Fontana H; Brookes G; Lees A; Marsden CD
    J Neurol Neurosurg Psychiatry; 1993 May; 56(5):526-30. PubMed ID: 8505645
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Botulinum toxin treatment for spasmodic dysphonia: percutaneous versus transoral approach.
    García Ruiz PJ; Cenjor Español C; Sanchez Bernardos V; Astarloa R; Sanabria J; García de Yébenes J
    Clin Neuropharmacol; 1998; 21(3):196-8. PubMed ID: 9617512
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Botulinum toxin treatment for spasmodic dysphonia.
    Kobayashi T; Niimi S; Kumada M; Kosaki H; Hirose H
    Acta Otolaryngol Suppl; 1993; 504():155-7. PubMed ID: 8470525
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Treatment of spasmodic dysphonia with botulinum toxin].
    Klap P; Marion MH; Perrin A; Fresnel-Elbaz E
    Ann Otolaryngol Chir Cervicofac; 1991; 108(8):477-82; discussion 482-3. PubMed ID: 1789624
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Botulinum toxin for spasmodic dysphonia.
    Rodriquez AA
    Phys Med Rehabil Clin N Am; 2003 Nov; 14(4):767-79. PubMed ID: 14580036
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Safety of simultaneous bilateral botulinum toxin injections for abductor spasmodic dysphonia.
    Stong BC; DelGaudio JM; Hapner ER; Johns MM
    Arch Otolaryngol Head Neck Surg; 2005 Sep; 131(9):793-5. PubMed ID: 16172357
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A comparison of the efficacy of unilateral versus bilateral botulinum toxin injections in the treatment of adductor spasmodic dysphonia.
    Maloney AP; Morrison MD
    J Otolaryngol; 1994 Jun; 23(3):160-4. PubMed ID: 8064952
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Double-blind controlled study of botulinum toxin in adductor spasmodic dysphonia.
    Troung DD; Rontal M; Rolnick M; Aronson AE; Mistura K
    Laryngoscope; 1991 Jun; 101(6 Pt 1):630-4. PubMed ID: 2041443
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-term therapy for spasmodic dysphonia: acoustic and aerodynamic outcomes.
    Mehta RP; Goldman SN; Orloff LA
    Arch Otolaryngol Head Neck Surg; 2001 Apr; 127(4):393-9. PubMed ID: 11296047
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of botulinum toxin injection procedures in adductor spasmodic dysphonia.
    Adams SG; Hunt EJ; Irish JC; Charles DA; Lang AE; Durkin LC; Wong DL
    J Otolaryngol; 1995 Dec; 24(6):345-51. PubMed ID: 8699600
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Physiologic assessment of botulinum toxin effects in the rat larynx.
    Inagi K; Connor NP; Ford CN; Schultz E; Rodriquez AA; Bless DM; Pasic T; Heisey DM
    Laryngoscope; 1998 Jul; 108(7):1048-54. PubMed ID: 9665255
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Unilateral versus bilateral thyroarytenoid Botulinum toxin injections in adductor spasmodic dysphonia: a prospective study.
    Upile T; Elmiyeh B; Jerjes W; Prasad V; Kafas P; Abiola J; Youl B; Epstein R; Hopper C; Sudhoff H; Rubin J
    Head Face Med; 2009 Oct; 5():20. PubMed ID: 19852852
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Results of using botulism toxin in the treatment of spasmodic dysphonia].
    Larrosa F; Idígora A; Aguilar F; Riera L; Martí MJ; Valls J
    Acta Otorrinolaringol Esp; 2002 Jan; 53(1):27-31. PubMed ID: 11998515
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The swallowing side effects of botulinum toxin type A injection in spasmodic dysphonia.
    Holzer SE; Ludlow CL
    Laryngoscope; 1996 Jan; 106(1 Pt 1):86-92. PubMed ID: 8544635
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Unilateral versus bilateral botulinum toxin injections in adductor spasmodic dysphonia.
    Langeveld TP; Drost HA; Baatenburg de Jong RJ
    Ann Otol Rhinol Laryngol; 1998 Apr; 107(4):280-4. PubMed ID: 9557760
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Resistance to botulinum toxin injections for spasmodic dysphonia.
    Smith ME; Ford CN
    Arch Otolaryngol Head Neck Surg; 2000 Apr; 126(4):533-5. PubMed ID: 10772310
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Botulinum toxin management of adductor spasmodic dysphonia after failed recurrent laryngeal nerve section.
    Sulica L; Blitzer A; Brin MF; Stewart CF
    Ann Otol Rhinol Laryngol; 2003 Jun; 112(6):499-505. PubMed ID: 12834116
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Botulinum toxin A injection under electromyographic guidance for treatment of spasmodic dysphonia.
    Casserly P; Timon C
    J Laryngol Otol; 2008 Jan; 122(1):52-6. PubMed ID: 17470307
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anatomic considerations in botulinum toxin type A therapy for spasmodic dysphonia.
    Castellanos PF; Gates GA; Esselman G; Song F; Vannier MW; Kuo M
    Laryngoscope; 1994 Jun; 104(6 Pt 1):656-62. PubMed ID: 8196438
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.